Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation ; day:6 ; month:10 ; year:2016 ; pages:1-7
Cancer immunology immunotherapy ; (6.10.2016), 1-7
- Urheber
-
Ellmark, Peter
- Beteiligte Personen und Organisationen
-
Mangsbo, Sara M.
Furebring, Christina
Norlèn, Per
TOETTERMAN, THOMAS H.
SpringerLink (Online service)
- DOI
-
10.1007/s00262-016-1909-3
- URN
-
urn:nbn:de:1111-2016110719818
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:48 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ellmark, Peter
- Mangsbo, Sara M.
- Furebring, Christina
- Norlèn, Per
- TOETTERMAN, THOMAS H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Profound tumor-specific Th2 bias in patients with malignant glioma
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Profound tumor-specific Th2 bias in patients with malignant glioma
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Profound tumor-specific Th2 bias in patients with malignant glioma